BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9354461)

  • 21. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
    Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
    Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.
    Yellin MJ; Sinning J; Covey LR; Sherman W; Lee JJ; Glickman-Nir E; Sippel KC; Rogers J; Cleary AM; Parker M
    J Immunol; 1994 Jul; 153(2):666-74. PubMed ID: 7517421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
    Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesion molecules in B-chronic lymphoproliferative disorders.
    Angelopoulou MK; Kontopidou FN; Pangalis GA
    Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.
    Forconi F; Raspadori D; Lenoci M; Lauria F
    Haematologica; 2005 Feb; 90(2):266-8. PubMed ID: 15710587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
    Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
    Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of CD40 ligand expression in B-cell chronic lymphocytic leukemia.
    Brugnoni D; Rossi G; Tucci A; Cattaneo R; Airò P
    Haematologica; 1995; 80(5):440-2. PubMed ID: 8566887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
    Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
    Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
    Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease.
    Agostini C; Zambello R; Sancetta R; Cerutti A; Milani A; Tassinari C; Facco M; Cipriani A; Trentin L; Semenzato G
    Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1359-67. PubMed ID: 8616567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.